Get the Stockscreener App
2.74
5.38%
0.14
Pre-market:
2.74
Okyo Pharma Limited stock is traded at $2.74, with a volume of 92,501.
It is up +5.38% in the last 24 hours and up +37.00% over the past month.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
See More
Previous Close:
$2.60
Open:
$2.6
24h Volume:
92,501
Relative Volume:
0.62
Market Cap:
$103.05M
Revenue:
-
Net Income/Loss:
$-13.27M
P/E Ratio:
-16.71
EPS:
-0.164
Net Cash Flow:
$-7.70M
1W Performance:
+14.64%
1M Performance:
+37.00%
6M Performance:
+72.87%
1Y Performance:
+132.20%
1-Day Range:
$2.60
$2.77
1-Week Range:
$2.40
$2.83
52-Week Range:
$0.9016
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
Compare OKYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.74 | 97.79M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Okyo Pharma Limited Stock (OKYO) Latest News
Long term hold vs stop loss in OKYO Pharma Limited - newser.com
How OKYO Pharma Limited (OK11) stock reacts to fiscal policiesPortfolio Gains Summary & Safe Capital Growth Trade Ideas - newser.com
How OKYO Pharma Limited stock valuations compare to rivalsProfit Target & Weekly Momentum Stock Picks - newser.com
What technical signals suggest for OKYO Pharma Limited stockJuly 2025 Breakouts & Safe Swing Trade Setups - newser.com
Will OKYO Pharma Limited (OK11) stock profit from automation waveWeekly Risk Summary & Safe Capital Growth Stock Tips - newser.com
Is OKYO Pharma Limited stock safe for conservative investors2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Individual investors invested in OKYO Pharma Limited (NASDAQ:OKYO) up 16% last week, insiders too were rewarded - simplywall.st
Key metrics from OKYO Pharma Limited’s quarterly dataQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Is OKYO Pharma Limited a candidate for recovery playWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
Will OKYO Pharma Limited (OK11) stock announce a stock split2025 Volatility Report & Technical Entry and Exit Tips - newser.com
Will OKYO Pharma Limited stock outperform Nasdaq index2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Market reaction to OKYO Pharma Limited’s recent news2025 Trading Recap & High Accuracy Trade Signal Alerts - newser.com
Strategies to average down on OKYO Pharma Limited2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Is OKYO Pharma Limited building a consolidation baseJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Will OKYO Pharma Limited (OK11) stock enhance shareholder valueJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
OKYO Pharma CEO to present at BIO-Europe conference in Vienna By Investing.com - Investing.com South Africa
OKYO Pharma CEO to present at BIO-Europe conference in Vienna - Investing.com UK
OKYO Pharma to present positive Phase 2 Data for urcosimod at BIO-Europe 2025 - Proactive financial news
OKYO Pharma to Present at BIO-Europe 2025 Highlighting Urcosimod Progress - TipRanks
OKYO Pharma to Present at BIO-Europe 2025 in Vienna - The Manila Times
How OKYO Pharma Limited stock reacts to inflationary pressures2025 Winners & Losers & Community Verified Trade Alerts - fcp.pa.gov.br
Okyo Pharma Limited Stock (OKYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):